Legal, Regulatory Matters and Contingencies (Details) $ in Thousands				1 Months Ended				3 Months Ended	12 Months Ended
	Jul. 28, 2017	Nov. 30, 2016 USD ($)	Apr. 16, 2013 a	Dec. 31, 2016 company	Nov. 30, 2016 item	Sep. 30, 2014 lawsuit	Jul. 31, 2014 lawsuit patent	Dec. 31, 2016 customer	Jun. 30, 2017 USD ($) lawsuit Distributor item patent	Nov. 24, 2015 USD ($)
Contingencies
Purchase of remaining noncontrolling interest									$ 1,500
Richard Asherman
Contingencies
Severance compensation, period			18 months
Amount of value sought of land (as a percent)			50.00%
Area of land | a			1.66
Purchase of remaining noncontrolling interest		$ 1,500
Government Pricing
Contingencies
Number of government entity customers for whom the Company completed a contract compliance review | customer								1
Best estimate of liability									$ 9,300
Indemnification asset										$ 8,300
Private Antitrust and Consumer Protection Litigation
Contingencies
Number of generic pharmaceutical manufacturers and distributors | Distributor									50
Number of generic drugs | item									18
Private Antitrust and Consumer Protection Litigation | Minimum
Contingencies
Number of lawsuits | lawsuit									100
Shareholder Litigation
Contingencies
Number of officers | item					2
Patent Infringement (Paragraph IV Certification)
Contingencies
Number of lawsuits | lawsuit						1	2
Patents allegedly invalid, number | patent									2
Patents allegedly invalid, unenforceable and/or not infringed, number | patent									15
Number of another entity allegedly infringed | patent							2
Braintree's response period for counterclaims	30 days
Connecticut Attorney General Inquiry
Contingencies
Number of companies | company				6